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Abstract
Background:  The use of herbal supplements in the United States has become increasingly
popular. The prevalence of herbal use among primary care patients varies in previous studies; the
pattern of herbal use among urban racially/ethnically diverse primary care patients has not been
widely studied. The primary objectives of this study were to describe the use of herbs by ethnically
diverse primary care patients in a large metropolitan area and to examine factors associated with
such use. The secondary objective was to investigate perceptions about and patterns of herbal use.
Methods: Data for a cross-sectional survey were collected at primary care practices affiliated with
the Southern Primary-care Urban Research Network (SPUR-Net) in Houston, Texas, from
September 2002 to March 2003. To participate in the study, patients had to be at least 18 years of
age and visiting one of the SPUR-Net clinics for routine, nonacute care. Survey questions were
available in both English and Spanish.
Results: A total of 322 patients who had complete information on race/ethnicity were included in
the analysis. Overall, 36% of the surveyed patients (n = 322) indicated use of herbs, with wide
variability among ethnic groups: 50% of Hispanics, 50% of Asians, 41% of Whites, and 22% of
African-Americans. Significant factors associated with an individual's herbal use were ethnicity
other than African-American, having an immigrant family history, and reporting herbal use by other
family members. About 40% of survey respondents believed that taking prescription medications
and herbal medicines together was more effective than taking either alone. One-third of herbal
users reported using herbs on a daily basis. More Whites (67%) disclosed their herbal use to their
health-care providers than did African-Americans (45%), Hispanics (31%), or Asians (31%).
Conclusions: Racial/ethnic differences in herbal use were apparent among this sample of urban
multiethnic adult primary care patients. Associated factors of herbal use were non-African-
American ethnicity, immigrant family history, and herbal use among family members. Whereas
Hispanics and Asians reported the highest rates of herbal use, they were the least likely to disclose
their use to health-care professionals. These findings are important for ensuring medication safety
in primary care practices.
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Background
The use of complementary and alternative medicine
(CAM) in the United States gained greater popularity in
the 1990s. Two national telephone surveys of 1,539 and
2,005 adults, respectively, demonstrated an increasing
trend in the use of CAM, including relaxation techniques,
herbal medicine, massage, chiropractic, and acupunc-
ture[1,2]. Specifically, the use of these unconventional
treatments rose from 33.8% in 1990 to 42.1% in 1997.
These surveys found that use of herbal medicine within
the past year increased from 2.5% in 1990 to 12.1% in
1997[2]. CAM use was also found to be more frequent
among females, persons 35 to 49 years of age, persons of
ethnicities other than African-American, persons who
were college educated, and persons whose annual income
was greater than $50,000[2]. In a separate study also con-
ducted in the 1990s, the American Botanical Council esti-
mated that one-third of the nation's adults use herbal
remedies[3].
Efficacy studies of herbal supplements are on the rise, but
most data published to date are preliminary and do not
provide strong evidence for the clinical effectiveness of
herbs. Nevertheless, about 15 million American adults
(18%) are thought to use prescription medications con-
currently with herbal or vitamin products[4], and as many
as 70% of persons who use herbal remedies do not discuss
their use of such remedies with their physicians or phar-
macists[1,5-7]. By not communicating about herbal use,
they may put themselves at increased risk for adverse
drug-herb interactions[8] and make it extremely difficult
for health-care professionals to monitor them for such
interactions[9]. Likewise, patients do not know what
symptoms they should report to their health-care provider
that indicate potential adverse effects of drug-herb interac-
tions. Consequently, unintentional medication errors
could occur.
The prevalence of herbal use among racially/ethnically
diverse primary care patients varies from study to
study[2,3,5-7,10-12], ranging from 30%[5,6] to 77%[7].
Since patients must interact with their primary care pro-
viders and pharmacists for illnesses to be diagnosed and
quality medical care to be provided, a better understand-
ing of variations in herbal use patterns among primary
care patients is needed. To this end, we conducted a study
with two objectives: 1) to describe the herbal use of ethni-
cally diverse patients in a large metropolitan area and to
examine factors associated with herbal use; and 2) to
investigate perceptions about and patterns of herbal use
among those patients.
Methods
Setting and study population
We implemented this cross-sectional study within the
Southern Primary-care Urban Research Network (SPUR-
Net) from September 2002 to March 2003. SPUR-Net is a
practice-based research network in Houston, Texas, that
consists of five constituent member organizations affili-
ated with a county health system, a managed care organi-
zation, or a private practice clinic. SPUR-Net clinicians
provide care to patients from diverse ethnic and socioeco-
nomic backgrounds, with approximately one million
patient visits per year. A total of six primary care clinics
were included in this study that varied according to socio-
economic status (SES) of their patients as measured by
income level and insurance type. For the purposes of this
study, we defined "clinic SES" according to the insurance
status of the majority of patients; "high SES" means that
most patients have insurance (i.e., private insurance and/
or Medicare), and "low SES" means most patients are
indigent (i.e., county health-care coverage and/or Medic-
aid). Human subject approvals were obtained from the
Institutional Review Boards at all of the SPUR-Net constit-
uent organizations. Permission to conduct the study was
also obtained from the medical directors and applicable
patient advisory groups at each of the six participating
clinics.
To be eligible for participation in the study, patients had
to be at least 18 years of age and to be visiting one of the
participating clinics for routine, nonacute care. A target of
50 surveys in each of the six clinics was collected from a
convenience sample of patients. The decision regarding
the number of patients to be surveyed was limited by our
resources, including availability in funding and person-
nel. A research assistant approached potential subjects in
the clinic setting to determine their willingness to com-
plete a 23-item questionnaire about herbal use in either
English or Spanish. Those patients who consented to par-
ticipate were either given the survey to complete on their
own or had the survey administered to them by the
research assistant. Research assistants were available on-
site to answer any questions the patients had, helping to
improve patients' understanding of the terms used in the
survey. Recruitment methods were the same in all of the
participating clinics. The research assistants stopped
recruiting patients when a minimum of 50 surveys was
collected in each clinic.
Survey instrument
Survey questions were adopted and modified from previ-
ously developed and validated surveys on CAM use,
including national telephone surveys conducted by Eisen-
berg et al.[1,2,13], a family practice survey by Elder et
al.[5], a research clinic survey by Johnson et al.[3], and a
national mail survey by Astin et al[14]. We modified theseBMC Complementary and Alternative Medicine 2004, 4:18 http://www.biomedcentral.com/1472-6882/4/18
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questions for use among our multiethnic patient popula-
tion; we also translated the survey questions into Spanish.
The survey instrument was pilot tested with 54 English-
speaking subjects and 10 Spanish-speaking subjects
before the study. The survey was reviewed by several
groups of patient representatives in the community health
centers to ensure consistency in responses. For example,
some members of a patient advisory group representing a
homeless clinic perceived herbal use to be marijuana use;
for this reason, we decided not to include this patient pop-
ulation in our study.
The final survey instrument had three components. First,
all participating patients answered questions regarding
sociodemographic characteristics (e.g., gender, age, race,
ethnicity, education, immigrant family history, herbal use
by other family members, spoken language other than
English, and clinic location). Immigrant family history
and spoken language were elicited with the following
questions: "Are your family members immigrants to the
United States (Y/N)?," and "Do you speak another lan-
guage other than English?" After completing the demo-
graphic questions, respondents answered a series of
questions regarding their belief in herbal use and their
herbal information sources. The questions pertained to
their personal use of herbs (Y/N); their belief in the bene-
fit of herbal remedies (Y/N), the source of their herbal
information (physician, pharmacist, family, friends, etc.);
their preferred content of herbal information (e.g., effec-
tiveness, side-effects, interactions with other medica-
tions), and their preferred methods for obtaining herbal
information from physicians or pharmacists (e.g., hand-
out, World Wide Web site, consultation). Patients who
reported using herbal supplements answered additional
questions related to their patterns of and reasons for
herbal use. In open-ended questions, the participating
patients were asked about the herbs they specifically used
and the health conditions for which they took the herbal
products. Related questions included frequency of herbal
use (daily, frequently-few times/month, occasionally—
few times/year); duration of use (< 1 year, 1–2 years, 3–5
years, > 5 years); expenditure on herbal products; reported
concomitant use of prescription medications; disclosure
of herbal use to physicians or pharmacists; and any expe-
riences of adverse reactions from using herbs.
For the purposes of this study, we used the definition of
dietary supplements stipulated in the 1994 Dietary Sup-
plement and Health Education Act (DSHEA) to differenti-
ate herbs from vitamins and minerals. Herbal use was
defined as having ever used herbal products or natural
medicines for health maintenance or treatment of health
conditions. To measure herbal use, we asked the follow-
ing question: "Do you use any of the following?"
Response options included: herbs/herbal products or nat-
ural medicine (e.g., echinacea, St. John's wort, ginseng,
ginkgo biloba, soy supplements), folk medicine or home
remedy, vitamins, minerals, or none. Herbal use did not
include the use of folk medicine, home remedies (such as
honey), vitamins, or minerals.
Data analysis
Data from the paper-based survey were entered into an
ACCESS database and were imported into SAS 9.1 for
Windows. The study variables were summarized by using
one-way frequencies to examine the sociodemographic
characteristics of the study sample, the belief in and infor-
mation source for herbal use, and the patterns of and rea-
sons for herbal use among urban multiethnic primary care
patients. The frequencies of use of specific herbs were
counted, and the health conditions for which herbs were
used were further coded into three types—acute, chronic,
and health maintenance.
Based on findings from previous studies, we used the fol-
lowing independent variables as reference variables for
both the univariate and multivariate logistic regression
analyses: male gender, age less than 30 years, African-
American ethnicity, less than a college education, no
immigrant family history, no herbal use by other family
members, and visiting a high SES clinic. A Chi-square test
of proportions was used to determine the association
between herbal use and each of the independent variables
related to demographic characteristics; a p value ≤ 0.05
was considered to be statistically significant. In order to
assess factors associated with herbal use, all hypothesized
variables (age, gender, race and ethnicity, education,
immigrant family history, herbal use by other family
members, and clinic clientele stratified by SES) were
included in both the univariate and the multivariate logis-
tic regression analyses. These independent variables were
entered as dichotomous variables in the model: gender
(male vs. female), age (< 50 years, ≥ 50 years), ethnicity
(African-American vs. other, including Whites and His-
panics), education (less than college vs. college and
greater), immigrant family history (yes vs. no), herbal use
by family members (yes vs. no), and clinic clientele (high
SES vs. low SES). Significant variables identified by back-
ward elimination of the main effects from the multivariate
analysis were further evaluated in two-way interactions.
Thus, the final model contained all of the significant main
effects and the two-way interaction terms. Odds ratios and
95% confidence intervals were calculated to determine
the effects of the significant variables on herbal use. Since
the sample size for Asians was small, Asians were not
included in the logistic regression analyses. Furthermore,
the language variable was excluded from the regression
analyses because the survey question was not clearly
answered by many patients; for example, 10 Spanish-lan-
guage forms had "no language other than English"BMC Complementary and Alternative Medicine 2004, 4:18 http://www.biomedcentral.com/1472-6882/4/18
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indicated. In addition, some answers were possibly indic-
ative of an exclusive language other than English instead
of the bilingual capability of the respondent.
Results
Description of sample
Of the 327 patients who agreed to participate in the sur-
vey, only 322 completed the race/ethnicity information
and were included in the analysis. The characteristics of
the study sample are summarized in Table 1. Two-thirds
of the patients were female, and approximately half of all
the patients had less than a college education. More than
a third (37%) of the patients reported having an immi-
grant family history, and 50 patients (15%) used the
Spanish-language form to complete the survey.
Herbal use
Overall, 36% of our study sample reported ever using
herbs. The proportions of herbal users varied across racial/
ethnic groups, with use being reported by 50% of Hispan-
ics, 50% of Asians, 41% of Whites, and 22% of African-
Americans. Herbal use by other family members was
reported to be 41% (57% among Hispanics, 45% among
Asians, 37% among Whites, and 30% among African-
Americans). Patients who reported using herbs indicated
that they received information about those herbs mainly
from family members and relatives. Nevertheless, most
patients reported that they preferred receiving herbal
information (e.g., on effectiveness, side-effects, and drug
interactions) through handouts or brochures from their
physicians or pharmacists, followed by having access to a
consultation service or a Web site. About 40% of all of the
survey respondents, but especially Asians (55%) and
Whites (47%), believed that taking prescription medica-
tions and herbal medicines together was more effective
than taking either alone. About 41% of Hispanic respond-
ents believed that herbal medicines were superior to pre-
scription medications, as compared to 12% of Whites.
These differences in beliefs about herbal use among the
ethnic groups were found to be statistically significant (p
< 0.05). Nearly half of the patients who reported using
herbs (46%), particularly Hispanics (63%) and Asians
(57%), also reported taking prescription medications con-
comitantly with the herbs (Table 2). Since our survey
question was designed to measure self-reported concomi-
tant herbal use and prescription drug use, we cannot con-
firm whether or not those who reported taking both were
actually using both.
Factors associated with herbal use
Variables demonstrating a significant univariate associa-
tion (p < 0.05) with herbal use were ethnicities other than
African-American, immigrant family history, and herbal
use by other family members (Table 3). In the
multivariate logistic regression model, non-African-Amer-
ican race/ethnicity (OR = 2.42, 95% CI, 1.33–4.40),
immigrant family history (OR = 2.23, 95% CI, 1.20–
4.14), and reported herbal use by other family members
(OR = 7.98, 95% CI, 4.48–14.18) remained significant
predictors of reported herbal use (p < 0.05). In addition,
Table 1: Descriptive Characteristics of the Study Sample (n = 322)
Variables White n (%) Hispanic n (%) African American n (%) Asian n (%)
Totals 68(21.1) 98(30.4) 136(42.2) 20(6.2)
Gender
Male 20(29.4) 34(34.7) 37(27.4) 7(35.0)
Female 48(70.6) 64(65.3) 98(72.6) 13(65.0)
Age (yrs)
< 30 13(19.1) 17(17.3) 27(19.8) 4(20.0)
30–49 34(50.0) 34(34.7) 47(34.6) 5(25.0)
50+ 21(30.9) 47(48.0) 62(45.6) 11(55.0)
Education
< High School 3(4.4) 52(53.0) 17(12.6) 0
High School 16(23.5) 23(23.5) 54(40.0) 5(25.0)
≥ College 49(72.1) 23(23.5) 64(47.4) 15(75.0)
Immigrant Family History
No 57(86.4) 41(41.8) 101(77.1) 0
Yes 9(13.6) 57(58.2) 30(22.9) 20(100.0)
Herbal Use by Other Family Members
No 43(63.2) 42(42.9) 95(69.9) 11(55)
Yes 25(36.8) 56(57.1) 41(30.1) 9(45)
Clinic Type
High SES Clinic 40(58.8) 14(14.3) 52(38.2) 9(45)
Low SES Clinic 28(41.2) 84(85.7) 84(61.8) 11(55)BMC Complementary and Alternative Medicine 2004, 4:18 http://www.biomedcentral.com/1472-6882/4/18
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interactions between immigrant family history and herbal
use by other family members were found to be significant
terms in the model (Table 3). With the race/ethnicity var-
iable adjusted, having an immigrant family history was
associated with a 19 times greater likelihood of herbal use
among those whose family members also use herbs.
When the analyses were run with the Asian group
included, the results did not change.
Perceptions about and patterns of herbal use
The reasons given by the study subjects for herbal use
included faster resolution of symptoms (47%), the desire
to try alternative therapies (33%), and preference for hav-
ing their own methods to care for their health (20%).
Among the herbal users, 32% reported taking herbs on a
daily basis, and 60% reported using herbs for longer than
three years. Usage varied by race/ethnicity; for example,
48% of Whites reported taking herbs on a daily basis, and
79% of Hispanics reported using herbs for longer than
three years.
Even though Hispanics and Asians used herbs more fre-
quently, they were the least likely to disclose their herbal
use to their physicians or pharmacists. More Whites
(67%) told their health-care professionals about their
herbal use than did the African-Americans (45%), His-
panics (31%), or Asians (31%). The reasons given for
nondisclosure generally fell into two main categories: 1)
"They (the provider) never asked," and 2) "It wasn't
important for them to know." While few respondents
(5.3%) reported having experienced an adverse reaction
to herbs, many of them (43%) did not inform their phy-
sicians of it.
Table 2: Patterns of and Reasons for Herbal Use Among Urban Multiethnic Primary Care Patients (n = 322)
Variables White n (%) Hispanic n (%) African American n (%) Asian n (%)
Herbal Use 28(41.2) 49(50.0) 30(22.1) 10(50.0)
Daily Herbal Use* 14(48.3) 13(22.8) 13(33.3) 4(30.8)
Herbal Use 3+ Years* 12(41.1) 45(78.9) 17(45.9) 7(53.8)
Report Taking Herbs and Prescription Medications for the Same 
Health Problems*
10(33.3) 36(63.2) 17(32.7) 8(57.1)
Told Physicians/Pharmacists About Herbal Use*
20(66.7) 17(30.9) 21(44.7) 4(30.8)
Had a Bad Reaction* 2(7.4) 1(2.0) 3(11.1) 0
Believed Both Prescription Medications and Herbal Medicines Are 
Better Than Either Alone**
Agree 32(47.1) 28(28.6) 54(40.6) 11(55.0)
Disagree 14(20.6) 44(44.9) 48(36.1) 6(30.0)
Neither 22(32.4) 26(26.5) 31(23.3) 3(15)
Believed Herbal Medicines Are Superior to Prescription 
Medications***
Agree 8(12.3) 40(41.2) 31(23.1) 6(30.0)
Disagree 36(55.4) 20(20.6) 62(46.3) 8(40.0)
Neither 21(32.3) 37(38.1) 41(30.6) 6(30.0)
Received Herbal Information (multiple)
Family or relatives 20(29.4) 60(61.2) 43(31.6) 10(50.0)
Magazines 24(35.3) 19(19.4) 38(27.9) 5(25.0)
Television 13(19.1) 24(24.5) 45(33.1) 0
Internet 12(17.7) 7(7.1) 9(6.6) 4(20)
Physician 10(14.7) 8(8.2) 12(8.8) 2(10.0)
Pharmacist 2(2.9) 2(2.0) 6(4.4) 0
Preferred Herbal Information (multiple)
Effectiveness 53(77.9) 72(73.5) 87(64.0) 9(45.0)
Side-effects 42(61.8) 76(77.6) 82(60.3) 12(60.0)
Interactions 46(67.7) 67(68.4) 75(55.2) 9(45.0)
Preferred Method for Obtaining Herbal Information (multiple)
Handout/Brochure 45(66.2) 80(81.6) 84(61.8) 11(55.0)
Website 25(36.8) 11(11.2) 20(14.7) 6(30.0)
Consultation 29(42.7) 20(20.4) 47(34.6) 5(25.0)
*Indicates only those patients who reported herbal use
**p = 0.008;*** p < 0.0001BMC Complementary and Alternative Medicine 2004, 4:18 http://www.biomedcentral.com/1472-6882/4/18
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The specific herbs used by the patients covered a wide
spectrum and varied by ethnicity. The herbs used most
commonly by White patients were echinacea (32.1%), St.
John's wort (21.4%), ginkgo biloba (14.3%), and chamo-
mile (14.3%). Hispanic patients most often reported
using chamomile (61.2%), aloe vera (44.9%), and garlic
(20.4%). African-American patients reported primarily
using garlic (40%), ginseng (30%), and ginkgo biloba
(10%). The herbs used by Asian patients were garlic
(50%), ginkgo biloba (30%), and ginger (30%). Other
herbs that were reported by patients—albeit infre-
quently—included Yun Zhi, black cohosh, dong quai,
guggle phosphate, bee pollen, cat claws, and "a shot of
whiskey." The patients who reported using herbs used
them for a wide range of health problems, such as boost-
ing the immune system, improving memory, and treating
insomnia, depression, or diabetes. For conditions consid-
ered to be chronic, 44% of the White patients reported
herbal use versus 32% of African-American patients. For
conditions considered to be acute, 71% of Hispanic
patients used herbs versus 10% of Asians. For health
maintenance, 50% of Asian patients used herbs versus
16% of Hispanic patients.
Discussion
Our data show that herbal use is common (36%) among
urban multiethnic primary care patients, but has a wide
variability among racial/ethnic groups. Hispanics and
Asians reported the highest rates of herbal use (50%), and
African Americans reported the lowest (22%). Previous
research conducted in the western United States found
that the prevalence of herbal use among racially/ethni-
cally diverse primary care patients varies[2,3,5-7,10-12],
ranging from 30% among primary care patients residing
in urban settings on the west coast of the United
States[5,6] to 77% among primary care patients residing
in the largest United States—Mexico border city[7].
As expected, factors associated with herbal use included
race/ethnicity, having an immigrant family history, and
herbal use by other family members. In addition, we
found interactions between having an immigrant family
history and herbal use by other family members. Previous
studies did not examine such interactions and found age
to be predictive of herbal use[2,6,7]. Unlike other investi-
gators, we did not find a significant relationship between
age and herbal use. Other investigators, however, did not
account for interactions such as those addressed in our
analysis. One study (n = 113) found no significant differ-
ences in the use of CAM therapies that could be attributa-
ble to gender, educational level, age, race, or clinic
attended[5]. Another study (n = 542) found an associa-
tion between the use of CAM therapies, high education
level, and female gender[6]. In addition, a recent study
conducted in a large United States—Mexico border city
revealed that 77% of the residents surveyed (n = 547) use
all modalities of CAM therapies and that such use was
associated with a high education level[7]. When the resi-
dents reported specifically using herbal and home reme-
dies (59%), however, herbal use was found to be
associated with a low education level[7].
We found that nearly half of herbal users (46%) reported
taking herbal medicines and prescription medications
concomitantly. More importantly, 43% of herbal users
reported not disclosing their herbal use to their physicians
or pharmacists. Interestingly, Hispanics and Asians used
herbs the most frequently but disclosed their herbal use to
their physicians or pharmacists less often than did Whites
and African Americans. This lack of communication about
herbal use is an area of concern because of the potential
for medication errors and untoward reactions to herb-
drug interactions. Adverse drug-herb interactions pose a
great danger for patients. For example, ginkgo biloba, gar-
lic, and ginseng all may interact with Coumadin® (warfa-
rin sodium) and cause an increase in bleeding
time[15,16]. Echinacea, an immunostimulant, can coun-
teract the action of the immunosuppressants (e.g., the cor-
ticosteroids prednisone, methotrexate, and cyclosporine)
used to treat immune disorders[17,18]. The interaction
between St. John's wort and cyclosporine—which is used
to treat rheumatoid arthritis and psoriasis and to prevent
the rejection of a transplanted organ—could result in
Table 3: Univariate Analysis of Factors Associated with Herbal 









Male 91 32(35.2) 0.9
Female 210 75(35.7)
Age (yrs)
< 30 106 34(32.1) 0.4
≥ 30 196 73(37.2)
Race/Ethnicity
African-American 136 30(22.1) <0.0001
White & Hispanic 166 77(46.4)
Education
< College 165 57(34.6) 0.8
≥ College 136 49(36.0)
Immigrant Family History
No 199 56(28.1) 0.0001
Yes 96 49(51.0)
Herbal Use by Other Family Members
No 180 31(17.2) <0.0001
Yes 122 76(62.3)
Clinic Type
High SES Clinic 106 35(33.0) 0.5
Low SES Clinic 196 72(36.7)BMC Complementary and Alternative Medicine 2004, 4:18 http://www.biomedcentral.com/1472-6882/4/18
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decreased availability of cyclosporine and, consequently,
to the worsening of arthritis or psoriasis or the rejection of
a transplanted organ [19-23]. St. John's wort may also
interact with antidepressants, such as monoamine oxidase
inhibitors (e.g., Nardil®, Parnate®) and potentiate the
effects of selective serotonin reuptake inhibitors (e.g.,
Paxil®, Prozac®, Zoloft®)[24]. Moreover, drug-herb interac-
tions might adversely affect the monitoring of certain drug
therapies and might even cause life-threatening complica-
tions. For example, ginseng, hawthorn, licorice, kyushin,
plantain, and uzara root have the potential to interfere
with the monitoring of Lanoxin® (digoxin)[25]. In addi-
tion, kava has been associated with hepatitis[26] and has
resulted in coma when used with Xanax®  (alpra-
zolam)[27]. As these detrimental effects have been real-
ized, concern about the increased use of herbal
supplements has grown[2,28-33].
Two-thirds of the patients we surveyed reported wanting
to receive information on herbal medicines from their
physicians or pharmacists, preferably in the form of a
handout or a brochure. These findings suggest that future
studies are warranted to develop and test educational
materials to 1) deepen our understanding of racial/ethnic
variation in herbal use among primary care patients; 2)
educate health-care professionals about the variations in
the use patterns and the rationales for use that may help
to reduce medication errors and increase the quality and
safety of medical care; and 3) educate patients regarding
evidence-based herbal information and encourage
patients to communicate their herbal use to their
physicians/pharmacists.
Our study results should be interpreted in the context of
several limitations. First, our estimates of herbal use fre-
quency are imprecise because we used a convenience sam-
ple instead of identifying patients by randomized
sampling. Secondly, even though we adopted the DSHEA
definition of herbs, some patients had difficulty under-
standing this definition. Specifically, a small group of
patients thought that herbs were equivalent to prescrip-
tion medications such as digoxin and aspirin; the patients'
level of understanding of herbs was improved after the
research assistants provided further explanation and clar-
ification. Third, we discovered that asking questions, such
as "What do you take when you run out of your medica-
tions?," was more effective in eliciting answers from the
study subjects than when asking them, "Do you use herbs,
herbal products or natural medicine?." For these reasons,
we had research assistants on-site to help facilitate the sur-
vey process. Fourth, the patients surveyed reported their
concomitant use of herbs with prescribed medications
based on their perceptions and memories. Last, we did not
include measures of quality of life or questions about
patient satisfaction with herbal use, which would be help-
ful in future studies, especially when comparing multieth-
nic and socioeconomically diverse patient groups.
Conclusions
Despite these limitations, our findings confirm the
increasing frequency of herbal use as reported in previous
studies. Our study also gives a unique perspective by
focusing on factors associated with reported herbal use
among an urban multiethnic primary care patient popula-
tion. In particular, we found that patients with immigrant
family history—especially those with family members
who use herbs—are most likely to report herbal use. Per-
haps most disconcerting was our finding that while an
increasing number of primary care patients report taking
herbal medicines concomitantly with prescription medi-
cations, many of them do not disclose their herbal use to
their physicians or pharmacists. These findings suggest
that primary care clinicians need to understand the extent
and patterns of herbal use by their multiethnic patients
and efforts to elicit information from patients about
herbal use may be warranted. Future studies are needed to
Table 4: Multiple Logistic Regression Analysis of Factors 
Associated with Herbal Use Among Urban Multiethnic Primary 
Care Patients (n = 302)







≥ 30 1.37 (0.74–2.55)
Race/Ethnicity
African-American 1.00
White & Hispanic 2.42* (1.33–4.40)
Education
< College 1.00









High SES Clinic 1.00
Low SES Clinic 0.80 (0.40–1.60)
Interactions
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develop effective interventions for primary care health-
care professionals and patients to improve medication
safety by eliminating potential adverse herb-drug interac-
tions and medication errors.
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